| CAS NO: | 1472624-85-3 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| Cas No. | 1472624-85-3 |
| 化学名 | [(1aS,2S,7aS)-1a,2,7,7a-tetrahydro-1H-cyclopropa[b]naphthalen-2-yl] 4-nitrobenzoate |
| Canonical SMILES | C1C2C1C(C3=CC=CC=C3C2)OC(=O)C4=CC=C(C=C4)[N+](=O)[O-] |
| 分子式 | C18H15NO4 |
| 分子量 | 309.32 |
| 溶解度 | DMF: 20 mg/ml,DMSO: 20 mg/ml,Ethanol: 0.5 mg/ml |
| 储存条件 | 4°C, protect from light |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | 7ACC2 is a new potent MCT inhibitor with IC50 of 11 nM for inhibition of [14C]-lactate influx; new antitumor treatment targeting lactate transport in cancer cells.IC50 value: 11 nM ([14C]-lactate influx) [1]Target: MCT inhibitor; lactate transport inhibitor7ACC2 did not influence the prothrombin time which, together with a good in vitro ADME profile, supports the potential of this new family of compounds to act as anticancer drugs through inhibition of lactate flux. References: |
m.cnreagent.com